Several compounds have been identified as potential inhibitors of MRPs, including flavonoids, cyclosporins, and certain synthetic molecules. For instance, MK-571 is a well-known inhibitor of MRP1. However, the clinical application of these inhibitors is still under investigation, with ongoing studies aiming to improve their efficacy and reduce side effects.